{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:19:38Z","timestamp":1774628378845,"version":"3.50.1"},"reference-count":31,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"unspecified","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Scheduled Castes and Scheduled Tribes Research and Training Institute, Government of Odisha","award":["1399\/R-01\/21"],"award-info":[{"award-number":["1399\/R-01\/21"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,2,13]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To estimate the prevalence of sickle cell trait, sickle cell disease, beta-thalassaemia minor and beta-thalassaemia major among Odisha\u2019s indigenous populations and to examine associated haematological profiles and survival outcomes based on socioeconomic factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A population-based cross-sectional study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Fourteen tribal-dominated districts of Odisha, eastern India<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>A total of 8774 tribal individuals aged 11 months to 99 years, selected using multistage cluster sampling from 9711 households.<\/jats:p>\n                    <jats:p>Primary and Secondary outcome:<\/jats:p>\n                    <jats:p>Primary outcomes were the prevalence of sickle cell trait, sickle cell disease, beta-thalassaemia minor and beta-thalassaemia major. Secondary outcomes included haemoglobin levels, serum iron, unsaturated iron-binding capacity, awareness regarding the diseases, nutritional status and estimated survival by sex and wealth quintile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The prevalence of sickle cell trait was 5.20%, sickle cell disease 0.40%, beta-thalassaemia minor 4.18%, and beta-thalassaemia major 0.44%. Females had slightly higher traits and minor prevalence, while the disease was more common in males; however, these differences are not statistically significant. Median serum iron levels were higher among individuals with \u03b2-thalassaemia major, while individuals with sickle cell disease exhibited consistently lower haemoglobin levels. Awareness was critically low (15.28%). Nutritional status and survival differed by condition, sex and wealth. Median survival was lowest for sickle cell disease and among the poorest, highlighting the need for targeted screening and education.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study highlights the substantial burden of haemoglobinopathies and significant health disparities among the Indigenous populations of Odisha. Expanding screening initiatives, enhancing health education and integrating haemoglobinopathy management into primary healthcare services are crucial for reducing disease burden and improving survival outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-108599","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:45:29Z","timestamp":1774626329000},"page":"e108599","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Haemoglobinopathies and health disparities: findings of a large-scale sample survey among indigenous populations in Odisha, India"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5356-9565","authenticated-orcid":false,"given":"Haimanti","family":"Bhattacharya","sequence":"first","affiliation":[{"name":"Dept. of Microbiology and One Health, ICMR - Regional Medical Research Centre Bhubaneswar, Bhubaneswar, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8356-7122","authenticated-orcid":false,"given":"Rachita","family":"Pradhan","sequence":"additional","affiliation":[{"name":"Dept. of Microbiology and One Health, ICMR - Regional Medical Research Centre Bhubaneswar, Bhubaneswar, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0796-350X","authenticated-orcid":false,"given":"Sneha","family":"Singh","sequence":"additional","affiliation":[{"name":"Dept. of Microbiology and One Health, ICMR - Regional Medical Research Centre Bhubaneswar, Bhubaneswar, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0967-7136","authenticated-orcid":false,"given":"A K","family":"Kavitha","sequence":"additional","affiliation":[{"name":"Dept. of Microbiology and One Health, ICMR - Regional Medical Research Centre Bhubaneswar, Bhubaneswar, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5199-5288","authenticated-orcid":false,"given":"Debdutta","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"Dept. of Microbiology and One Health, ICMR - Regional Medical Research Centre Bhubaneswar, Bhubaneswar, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8719-4539","authenticated-orcid":false,"given":"Jaya Singh","family":"Kshatri","sequence":"additional","affiliation":[{"name":"Dept. of Microbiology and One Health, ICMR - Regional Medical Research Centre Bhubaneswar, Bhubaneswar, India"},{"name":"Maastricht University Medical Centre+, Maastricht, LI, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7717-5592","authenticated-orcid":false,"given":"Sanghamitra","family":"Pati","sequence":"additional","affiliation":[{"name":"Dept. of Microbiology and One Health, ICMR - Regional Medical Research Centre Bhubaneswar, Bhubaneswar, India"},{"name":"Indian Council of Medical Research, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"2026032708451586000_16.3.e108599.1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12687-019-00410-1","article-title":"Haemoglobinopathies in India: estimates of blood requirements and treatment costs for the decade 2017\u20132026","volume":"11","author":"Sinha","year":"2020","journal-title":"J Community Genet"},{"key":"2026032708451586000_16.3.e108599.2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000\u20132021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"10","author":"Thomson","year":"2021","journal-title":"Lancet Haematol"},{"key":"2026032708451586000_16.3.e108599.3","unstructured":"Gorakshakar AC . Epidemiology of sickle hemoglobin in india."},{"key":"2026032708451586000_16.3.e108599.4","unstructured":"National sickle cell anaemia elimination mission. 2025. Available: https:\/\/sickle.nhm.gov.in\/"},{"key":"2026032708451586000_16.3.e108599.5","unstructured":"OperationalGuidelines.pdf. 2025. Available: https:\/\/sickle.nhm.gov.in\/uploads\/english\/OperationalGuidelines.pdf"},{"key":"2026032708451586000_16.3.e108599.6","unstructured":"List of communities | st & sc development, minorities & backward classes welfare department. 2025. Available: https:\/\/stsc.odisha.gov.in\/about-us\/list-of-communities"},{"key":"2026032708451586000_16.3.e108599.7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4103\/0971-5916.159488","article-title":"Haemoglobinopathies in tribal populations of India","volume":"141","author":"Ghosh","year":"2015","journal-title":"Indian J Med Res"},{"key":"2026032708451586000_16.3.e108599.8","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.4103\/jfmpc.jfmpc_2192_21","article-title":"Health research in the state of Odisha, India: A decadal bibliometric analysis","volume":"11","author":"Kshatri","year":"2011","journal-title":"J Family Med Prim Care"},{"key":"2026032708451586000_16.3.e108599.9","doi-asserted-by":"crossref","unstructured":"Brandow AM , Liem RI . n.d. Advances in the diagnosis and treatment of sickle cell disease. J Hematol Oncol 15. doi:10.1186\/s13045-022-01237-z","DOI":"10.1186\/s13045-022-01237-z"},{"key":"2026032708451586000_16.3.e108599.10","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1157241","article-title":"Odisha tribal family health survey: methods, tools, and protocols for a comprehensive health assessment survey","volume":"11","author":"Kshatri","year":"2023","journal-title":"Front Public Health"},{"key":"2026032708451586000_16.3.e108599.11","unstructured":"Deb Roy A , Das D , Mondal H . The Tribal Health System in India: Challenges in Healthcare Delivery in Comparison to the Global Healthcare Systems. Cureus 2025;15."},{"key":"2026032708451586000_16.3.e108599.12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.4103\/ijcm.IJCM_558_19","article-title":"Digital Hemoglobinometers as Point-of-Care Testing Devices for Hemoglobin Estimation: A Validation Study from India","volume":"45","author":"Yadav","year":"2020","journal-title":"Indian J Community Med"},{"key":"2026032708451586000_16.3.e108599.13","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.639208","article-title":"Evaluation of Microchip-Based Point-Of-Care Device \u201cGazelle\u201d for Diagnosis of Sickle Cell Disease in India","volume":"8","author":"Shrivas","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2026032708451586000_16.3.e108599.14","doi-asserted-by":"crossref","unstructured":"Bhattacharya H , Parai D , Sahoo SK , et al . Hepatitis B virus infection among the tribal and particularly vulnerable tribal population from an eastern state of India: Findings from the serosurvey in seven tribal dominated districts, 2021\u20132022. Front Microbiol 2021;14. doi:10.3389\/fmicb.2023.1039696","DOI":"10.3389\/fmicb.2023.1039696"},{"key":"2026032708451586000_16.3.e108599.15","unstructured":"R: the r project for statistical computing. 2025. Available: https:\/\/www.r-project.org\/"},{"key":"2026032708451586000_16.3.e108599.16","unstructured":"Statistical software for data science | stata. 2025. Available: https:\/\/www.stata.com\/"},{"key":"2026032708451586000_16.3.e108599.17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/ijph.ijph_766_22","article-title":"Pattern of hemoglobinopathy among the young tribes of West Bengal: A completely different scenario from Rest of India","volume":"67","author":"Shaw","year":"2023","journal-title":"Indian J Public Health"},{"key":"2026032708451586000_16.3.e108599.18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4103\/0971-5916.159488","article-title":"Haemoglobinopathies in tribal populations of India","volume":"141","author":"Ghosh","year":"2015","journal-title":"Indian Journal of Medical Research"},{"key":"2026032708451586000_16.3.e108599.19","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5916.159492"},{"key":"2026032708451586000_16.3.e108599.20","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/13548506.2018.1533985","article-title":"Gender influences on the health of adolescents with sickle cell disease","volume":"24","author":"Barton-Gooden","year":"2019","journal-title":"Psychol Health Med"},{"key":"2026032708451586000_16.3.e108599.21","doi-asserted-by":"crossref","unstructured":"Yadav PK , Singh AK . A Review of Iron Overload in Beta-Thalassemia Major, and a Discussion on Alternative Potent Iron Chelation Targets. Clin Med Insights Blood Disord 2022. doi:10.1177\/26348535221103560","DOI":"10.1177\/26348535221103560"},{"key":"2026032708451586000_16.3.e108599.22","doi-asserted-by":"crossref","unstructured":"Mudiyanselage Dilhara Sewwandi Karunaratna A , Shirani Ranasingha J , Mudiyanselage Mudiyanse R . n.d. Iron overload in beta thalassemia major patients. Int J Blood Transfus Immunohematol 7:1\u20138. doi:10.5348\/ijbti-2017-32-OA-5","DOI":"10.5348\/ijbti-2017-32-OA-5"},{"key":"2026032708451586000_16.3.e108599.23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/pbc.25882","article-title":"MRI Measurements of Iron Load in Transfusion-Dependent Patients: Implementation, Challenges, and Pitfalls","volume":"63","author":"Quinn","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"2026032708451586000_16.3.e108599.24","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.265"},{"key":"2026032708451586000_16.3.e108599.25","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.951947","article-title":"Barriers to adherence to iron chelation therapy among adolescent with transfusion dependent thalassemia","volume":"10","author":"Mohamed","year":"2022","journal-title":"Front Pediatr"},{"key":"2026032708451586000_16.3.e108599.26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.10233"},{"key":"2026032708451586000_16.3.e108599.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05339.x"},{"key":"2026032708451586000_16.3.e108599.28","doi-asserted-by":"crossref","unstructured":"Kumar A , Bhattacharya S . Sickle cell disease: a comparative perspective on global and national initiatives. Front Hematol 2024;3. doi:10.3389\/frhem.2024.1457158","DOI":"10.3389\/frhem.2024.1457158"},{"key":"2026032708451586000_16.3.e108599.29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1353\/hpu.2012.0127","article-title":"Hemoglobinopathy Learning Collaborative: using quality improvement (QI) to achieve equity in health care quality, coordination, and outcomes for sickle cell disease","volume":"23","author":"Oyeku","year":"2012","journal-title":"J Health Care Poor Underserved"},{"key":"2026032708451586000_16.3.e108599.30","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2013.062","article-title":"Sickle cell disease: management options and challenges in developing countries","volume":"5","author":"Ansong","year":"2013","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"2026032708451586000_16.3.e108599.31","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-013-1346-2"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-108599","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:45:40Z","timestamp":1774626340000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-108599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,27]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bmjopen-2025-108599"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-108599","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}